Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Iva Pitner, Mislav Mikuš, Marina Šprem Goldštajn, Antonio Simone Laganà, Vito Chiantera, Federico Ferrari, Mohsin Shah, Maurizio Nicola D’Alterio, Salvatore Giovanni Vitale & Stefano Angioni. (2023) Effects of different progesterone levels on reproductive outcomes in assisted reproductive technologies: from molecular basis to treatment strategies. Gynecological Endocrinology 39:1.
Read now
Read now
Vendy Zajec, Mislav Mikuš, Salvatore Giovanni Vitale, Maurizio Nicola D’alterio, Marija Gregov, Marko Jakov Šarić, Jose Carugno, Stefano Angioni & Mario Ćorić. (2022) Current status and challenges of drug development for hormonal treatment of endometriosis: a systematic review of randomized control trials. Gynecological Endocrinology 38:9, pages 713-720.
Read now
Read now
Yasemin Kizilkaya, Mujde Can Ibanoglu, Sadiman Kıykac Altinbas & Yaprak Engin-Ustun. (2022) A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecological Endocrinology 38:5, pages 403-406.
Read now
Read now
Ilaria Piacenti, Maria Federica Viscardi, Luisa Masciullo, Chiara Sangiuliano, Sara Scaramuzzino, Maria Grazia Piccioni, Ludovico Muzii, Pierluigi Benedetti Panici & Maria Grazia Porpora. (2021) Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice?. Gynecological Endocrinology 37:5, pages 471-475.
Read now
Read now
Articles from other publishers (26)
Antonio Maiorana, Marianna Maranto, Vincenzo Restivo, Daniele Lo Gerfo, Gabriella Minneci, Antonella Mercurio & Domenico Incandela. (2023) Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis. Archives of Gynecology and Obstetrics.
Crossref
Crossref
Alexa Eberle, Dong Bach Nguyen, Jessica Papillon Smith, Fady W. Mansour, Srinivasan Krishnamurthy & Andrew Zakhari. (2023) Medical Management of Ovarian Endometriomas. Obstetrics & Gynecology.
Crossref
Crossref
Hervé Fernandez, Aubert Agostini, Hortense Baffet, Nathalie Chabbert-Buffet, Philippe Descamps, Jean-Philippe Estrade, Géraldine Giraudet, Claude Hocke, Bruno Salle, Florence Tremollieres & Charles Chapron. (2023) Update on the management of endometriosis-associated pain in France. Journal of Gynecology Obstetrics and Human Reproduction 52:9, pages 102664.
Crossref
Crossref
Ilaria Alasia, Aubert Agostini, Cindy Faust, Julie Berbis & Audrey Pivano. (2023) Effect of hormonal treatment on evolution of endometriomas: An observational study. Journal of Gynecology Obstetrics and Human Reproduction 52:9, pages 102637.
Crossref
Crossref
Simona Del Forno, Benedetta Orsini, Ludovica Verrelli, Martina Caroli, Anna Chiara Aru, Jacopo Lenzi, Diego Raimondo, Alessandro Arena, Giulia Borghese, Roberto Paradisi, Maria Cristina Meriggiola, Renato Seracchioli & Paolo Casadio. (2023) Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study. Archives of Gynecology and Obstetrics 308:4, pages 1341-1349.
Crossref
Crossref
Surekha Tayade, Sangeeta Rai, Hrishikesh Pai, Madhuri Patel & Nidhi Makhija. (2023) Efficacy of Dienogest in Adolescent Endometriosis: A Narrative Review. Cureus.
Crossref
Crossref
Ludovico Muzii, Giulia Galati, Giulia Mattei, Alessandra Chinè, Giorgia Perniola, Violante Di Donato, Chiara Di Tucci & Innocenza Palaia. (2023) Expectant, Medical, and Surgical Management of Ovarian Endometriomas. Journal of Clinical Medicine 12:5, pages 1858.
Crossref
Crossref
Pilar Carrillo Torres, M. Ángeles Martínez-Zamora, Cristina Ros, Mariona Rius, Eduard Mensión, Meritxell Gracia & Francisco Carmona. (2023) Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up. Scientific Reports 13:1.
Crossref
Crossref
Bilgehan Saglik Gokmen, Nura F Topbas Selcuki, Alev Aydın, Pinar Yalcin Bahat & Aysu Akça. (2023) Effects of Dienogest Therapy on Endometriosis-Related Dysmenorrhea, Dyspareunia, and Endometrioma Size. Cureus.
Crossref
Crossref
Su Hyeon Choi, Sujin Kim, Si Won Lee, Seyeon Won, So Hyun Shim, Nara Lee, Mi Kyoung Kim, Yong Wook Jung, Seok Ju Seong & Mi-La Kim. (2023) Recurrence, Reoperation, Pregnancy Rates, and Risk Factors for Recurrence after Ovarian Endometrioma Surgery: Long-Term Follow-Up of 756 Women. Yonsei Medical Journal 64:3, pages 204.
Crossref
Crossref
I. A. Ivanov. (2022) The issues of endometriosis hormonal treatment in reproductive age women. Meditsinskiy sovet = Medical Council:6, pages 157-163.
Crossref
Crossref
Tommaso Capezzuoli, Margherita Rossi, Francesco La Torre, Silvia Vannuccini & Felice Petraglia. (2022) Hormonal drugs for the treatment of endometriosis. Current Opinion in Pharmacology 67, pages 102311.
Crossref
Crossref
Yuguang Chen, Ge Yang & Yining Zhao. (2022) Application of Dienogest In the Treatment of Endometriosis. Highlights in Science, Engineering and Technology 8, pages 69-73.
Crossref
Crossref
Wei-Guo Nicholas Loh, Nira Borok, Lyndal Anderson & Tanushree Rao. (2022) An Unusual Case of a Large Extraovarian Endometrioma in an Adolescent. Case Reports in Obstetrics and Gynecology 2022, pages 1-5.
Crossref
Crossref
Silvia Vannuccini, Sara Clemenza, Margherita Rossi & Felice Petraglia. (2021) Hormonal treatments for endometriosis: The endocrine background. Reviews in Endocrine and Metabolic Disorders 23:3, pages 333-355.
Crossref
Crossref
Emmanuelle Mathieu d’Argent. 2022. Chirurgie de L'endométriose. Chirurgie de L'endométriose
44
56
.
Maurizio Nicola D’Alterio, Stefania Saponara, Mirian Agus, Antonio Simone Laganà, Marco Noventa, Emanuela Stochino Loi, Anis Feki & Stefano Angioni. (2021) Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review. Gynecological Surgery 18:1.
Crossref
Crossref
Renuka Malik & Manmeet Kaur Mann. (2021) Role of Dienogest in Endometriosis in Young Women. The Journal of Obstetrics and Gynecology of India 71:5, pages 522-529.
Crossref
Crossref
Shao-Chong Lin, Xin-Yue Wang, Xi-Ling Fu, Wen-Hui Yang, Han Wu, Yang Bai, Zhong-Na Shi, Jun-Peng Du & Bao-Jin Wang. (2021) Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis. World Journal of Meta-Analysis 9:4, pages 377-388.
Crossref
Crossref
I. V. Kuznetsova. (2021) Empirical and long-term therapy for endometriosis-associated pelvic pain. Medical alphabet:8, pages 8-12.
Crossref
Crossref
Galina E. Chernukha, Madina R. Dumanovskaya & Lilia M. Ilina. (2021) Ovarian endometriosis and fertility preservation problem. Gynecology 23:2, pages 110-116.
Crossref
Crossref
Maurizio N. D’ALTERIO, Carlotta GIULIANI, Francesco SCICCHITANO, Antonio S. LAGANÀ, Noemi M. OLTOLINA, Felice SORRENTINO, Luigi NAPPI, Germano ORRÙ & Stefano ANGIONI. (2021) Possible role of microbiome in the pathogenesis of endometriosis. Minerva Obstetrics and Gynecology 73:2.
Crossref
Crossref
Michele VIGNALI, Eugenio SOLIMA, Valeria BARBERA, Chiara BECHERINI & Gaia M. BELLONI. (2021) Approaching ovarian endometrioma with medical therapy. Minerva Obstetrics and Gynecology 73:2.
Crossref
Crossref
Daniela Chemogo-Gbellu. (2020) Endometriose, aktuelle medikamentöse Therapieempfehlungen mit Schwerpunkt auf der hormonellen Therapie mit GestagenenEndométriose, recommandations actuelles concernant la pharmacothérapie et plus particulièrement le traitement hormonal progestatif. Journal für Gynäkologische Endokrinologie/Schweiz 23:4, pages 156-159.
Crossref
Crossref
Fabio Barra, Antonio Simone Laganà, Carolina Scala, Simone Garzon, Fabio Ghezzi & Simone Ferrero. (2020) Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reproductive BioMedicine Online 41:5, pages 859-868.
Crossref
Crossref
A. V. Kozachenko. (2020) Hormone therapy for patients with endometriosis: status update on the problem (literature review). Meditsinskiy sovet = Medical Council:13, pages 116-123.
Crossref
Crossref